Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Arun Sanyal

Newcastle AuthorsTitleYearFull text
Professor Arun Sanyal
Professor Quentin Anstee
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients With MASH2025
Professor Arun Sanyal
Professor Pierre Bedossa
Professor Quentin Anstee
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis2024
Professor Fiona Oakley
Dr Simon Cockell
Dr Olivier Govaere
Professor Ann Daly
Professor Arun Sanyal
et al.		An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)2024
Professor Quentin Anstee
Professor Arun Sanyal
NIS2+TM as a screening tool to optimize patient selection in metabolic dysfunction-associated steatohepatitis clinical trials2024
Professor Arun Sanyal
Professor Quentin Anstee
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis2023
Professor Cliff Brass
Professor Arun Sanyal
Professor Quentin Anstee
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis2023
Professor Arun Sanyal
Professor Quentin Anstee
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis2022
Dr Marie Boyle
Professor Stuart McPherson
Professor Arun Sanyal
Professor Quentin Anstee
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD—not everyone fits the mould. Authors' reply2022
Professor Quentin Anstee
Professor Arun Sanyal
Noninvasive Evaluation of Response to Obeticholic Acid in Patients with NASH: Results from the REGENERATE Study2022
Professor Helen Reeves
Professor Arun Sanyal
Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878]2021
Professor Quentin Anstee
Professor Arun Sanyal
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study2021
Dr Catherine Willoughby
Professor Helen Reeves
Professor Arun Sanyal
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis2021
Professor Pierre Bedossa
Professor Quentin Anstee
Professor Arun Sanyal
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study2020
Professor Arun Sanyal
Professor Quentin Anstee
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial2020
Dr Matthew Breckons
Dr Yemi Oluboyede
Professor Luke Vale
Professor Laura Ternent
Professor Arun Sanyal
et al.		Evaluating the patient-perceived impact of non-alcoholic steatohepatitis with compensated cirrhosis2020
12